StockWatch
·
Pharmaceuticals
Board Meeting22 Oct 2026, 03:17 pm

Unjha Formulations Board Meeting on Nov 5 to Approve Q2 FY27 Results

AI Summary

Unjha Formulations Ltd has announced that its Board of Directors will convene on November 5, 2026. The primary agenda item is to consider and approve the Un-Audited Financial Results for the Half Year and Quarter Ended September 30, 2026, for the Financial Year 2026-27. The meeting is scheduled to take place at the company's registered office.

Key Highlights

  • Board meeting scheduled for November 5, 2026.
  • To consider and approve financial results for H1 and Q2 FY27.
  • Results will be un-audited.
  • Meeting to be held at the registered office.